In accordance with previous reports on genetically determined autoimmune diseases through compromised CTLA-4, clinical manifestations vary between patients due to the lowered thresholds of inhibitory T cell function, rather than through specific triggers51. This evidence concerns the gene CTLA4 and autoimmune disease.